arrow
B

Bellinda L. King-Kallimanis

lungevity foundation institution
H指数:32
被引数:3,770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PRO‑CTCAE in Oncology Drug Evaluation: Cross-Agency Review of Regulatory and Health Technology Assessment Decision-Making in the United States and Europe

PRO-CTCAE在肿瘤药物评估中的应用:美国和欧洲跨机构监管与卫生技术评估决策制定的审查

2026-09-110
OAAI
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

推进以患者为中心的护理: 在早期临床试验中整合患者报告的结果进行耐受性评估-来自专家虚拟圆桌会议的见解

2024-10-010
OAAI
Recommendations to address respondent burden associated with patient-reported outcome assessment
2024-02-2919
OA